133 related articles for article (PubMed ID: 20514505)
1. Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis.
Yamano T; Morii E; Arai I; Takada T; Kubota K; Sato M; Inoue T; Okada Y; Hara T; Aozasa K
Int J Clin Oncol; 2010 Dec; 15(6):621-5. PubMed ID: 20514505
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.
Mori R; Futamura M; Morimitsu K; Saigo C; Miyazaki T; Yoshida K
World J Surg Oncol; 2017 Jun; 15(1):117. PubMed ID: 28662703
[TBL] [Abstract][Full Text] [Related]
3. [Multiple primary malignancies in BRCA1 mutation carriers--two clinical cases].
Badora A; Kaleta B; Nowara E; Sikora-Jopek M; Budryk M; Smok-Ragankiewicz A
Ginekol Pol; 2013 Oct; 84(10):892-6. PubMed ID: 24273914
[TBL] [Abstract][Full Text] [Related]
4. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
5. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
Takeshita N; Fukunaga T; Kimura M; Sugamoto Y; Tasaki K; Hoshino I; Ota T; Maruyama T; Tamachi T; Hosokawa T; Asai Y; Matsubara H
World J Gastroenterol; 2015 Nov; 21(44):12722-8. PubMed ID: 26640350
[TBL] [Abstract][Full Text] [Related]
6. Metastatic colon cancer of the small intestine diagnosed using genetic analysis: a case report.
Matsuo M; Hatano Y; Imaizumi Y; Kuroda T; Arai T; Tomita H; Matsuhashi N; Yoshida K; Hara A
Diagn Pathol; 2020 Aug; 15(1):106. PubMed ID: 32867793
[TBL] [Abstract][Full Text] [Related]
7. Single alteration of p53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer.
Pocard M; Debruyne P; Bras-Gonçalves R; Mareel M; Dutrillaux B; Poupon MF
Dis Colon Rectum; 2001 Aug; 44(8):1106-12. PubMed ID: 11535849
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic tumors in the ovary, difficulties of histologic diagnosis].
Tamás J; Vereczkey I; Tóth E
Magy Onkol; 2015 Sep; 59(3):205-13. PubMed ID: 26339910
[TBL] [Abstract][Full Text] [Related]
9. Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis.
Kaneki E; Oda Y; Ohishi Y; Tamiya S; Oda S; Hirakawa T; Nakano H; Tsuneyoshi M
Hum Pathol; 2004 Dec; 35(12):1484-93. PubMed ID: 15619207
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study on p53 gene mutation in primary human Dukes C colon cancer with that in matched lymph node metastasis].
Zhang J; Caplin S; Benhattar J
Zhonghua Bing Li Xue Za Zhi; 1997 Apr; 26(2):85-8. PubMed ID: 10072877
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
12. Significance of SATB2 expression in colon cancer and its differential diagnosis in digestive tract adenocarcinoma and ovarian primary and metastatic carcinoma.
Liu F; Gao Z; Shen D; Zhao H; Wang C; Ye Y; Ma Y; Kong F
Pathol Res Pract; 2019 Jul; 215(7):152430. PubMed ID: 31101576
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
Loy TS; Calaluce RD; Keeney GL
Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
16. Late Development of Metastatic Ovarian Mucinous Adenocarcinoma From Primary Gallblader Adenocarcinoma and High-grade Dysplasia.
Taylor J; Shah R; McElvanna K; Kelly PJ; McCluggage WG
Int J Gynecol Pathol; 2021 Jan; 40(1):41-48. PubMed ID: 32897957
[TBL] [Abstract][Full Text] [Related]
17. Distant metastases in ovarian cancer: association with p53 mutations.
Sood AK; Sorosky JI; Dolan M; Anderson B; Buller RE
Clin Cancer Res; 1999 Sep; 5(9):2485-90. PubMed ID: 10499623
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of primary versus metastatic pulmonary adenocarcinomas using gene mutation analyses: a case report.
Nakazato Y; Tanaka R; Seki E; Iijima M; Kojima M; Yoshizumi M; Kato M; Kimura H; Kozawa K; Goya T
J Thorac Oncol; 2008 Aug; 3(8):931-4. PubMed ID: 18670315
[TBL] [Abstract][Full Text] [Related]
19. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type.
Finkelstein SD; Sayegh R; Christensen S; Swalsky PA
Cancer; 1993 Jun; 71(12):3827-38. PubMed ID: 8508351
[TBL] [Abstract][Full Text] [Related]
20. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.
Sakai K; Kaku T; Kamura T; Kinukawa N; Amada S; Shigematsu T; Hirakawa T; Kobayashi H; Ariyoshi K; Nakano H
Gynecol Oncol; 1999 Mar; 72(3):360-6. PubMed ID: 10053108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
